Search Tag: Moderna
2022 20 Sep
Bexson Biomedical, Inc., a biopharmaceutical company focused on disrupting the $189 billion small molecule injectable market and enabling home health solutions announced the appointment of Robert S. Langer ScD, MIT David H. Koch Institute Professor and Co-founder of Moderna, to its Scientific Advisory Board (SAB). "We are excited to have Dr. Langer...Read more
2022 11 Apr
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines has announced that Jorge Gomez will join Moderna as Chief Financial Officer, effective Monday, May 9, 2022. He will serve on Moderna's Executive Committee and report to Chief Executive Officer, Stéphane Bancel. "I am pleased to welcome Jorge to Moderna...Read more
2022 16 Mar
The Society of Breast Imaging (SBI) now recommends that women should not delay mammograms due to COVID-19 vaccinations. Lymph node swelling caused by vaccination presented a concern for false positives because this is a signal also associated with cancer. Women were advised in 2021 to delay mammograms to avoid false-positive results and unnecessary...Read more
2021 20 Apr
Over the last week the COVID-19 vaccine landscape has once again changed drastically, with the use of J&J’s Janssen suspended in many countries and new players attracting more attention. You might also like: Shortages of COVID-19 vaccine supplies are being felt globally, not excluding the EU and the UK. Do companies fulfil their obligations...Read more
2021 29 Mar
Shortages of COVID-19 vaccine supplies are being felt globally, not excluding the EU and the UK. Do companies fulfil their obligations and where will new manufacturing facilities be created? You might also like: Why has AstraZeneca’s COVID-19 vaccine been the centre of attention in Europe over the past few days? Learn more...Read more
2021 17 Mar
Moderna has begun testing its COVID-19 vaccine in children ages 6 months to less than 12 years. This is the first such study with paediatric participants. You might also like: Moderna and IBM will work together on implementation of technologies such as artificial intelligence, blockchain and hybrid cloud, to improve COVID-19 vaccine management...Read more
2021 05 Mar
The vaccine manufacturer Moderna and IBM, a technology company, will work together on implementation of technologies such as artificial intelligence, blockchain and hybrid cloud, to improve COVID-19 vaccine management in the U.S. You might also like: An interview with European and U.S. e xperts about the need for global...Read more
2020 02 Dec
The UK, first in the world, authorises Pfizer COVID-19 vaccine and is looking into fast-tracking AstraZeneca’s. In the meantime, Pfizer and Moderna both file applications for their vaccines’ emergency use in the U.S. and Europe. You might also like: Coronavirus, Tensegrity and CSR: Year of Living Dangerously The...Read more
2020 18 Nov
Pfizer has completed the Phase 3 of its COVID-19 vaccine trial and is ready to seek authorisation for emergency use in the U.S. The vaccine is reported to be 95% effective. Two other vaccine candidates, those of Moderna and the Russian Gamaleya Research Institute, demonstrated 94.5% and 92% efficacy, respectively, but the trials are still...Read more